Abstract: The embodiments provide a transformable robot mechanism and an inspection robot. The robot mechanism includes a functional device box, balance side shells, a battery cell, and a control panel. The balance side shells are rotatably installed on two sides of the functional device box respectively, wherein the balance side shells on one side of the functional device box are internally provided with the battery cell, and the balance side shells on the other side of the functional device box are internally provided with the control panel. The balance side shells are detachably connected to the functional device box. The inspection robot includes the robot mechanism, a robot movement assembly, and a vision assembly. The robot movement assembly is installed in the functional device box and is configured to drive the robot mechanism to move.

Abstract: The embodiments provide a transformable robot mechanism and an inspection robot. The robot mechanism includes a functional device box, balance side shells, a battery cell, and a control panel. The balance side shells are rotatably installed on two sides of the functional device box respectively, wherein the balance side shells on one side of the functional device box are internally provided with the battery cell, and the balance side shells on the other side of the functional device box are internally provided with the control panel. The balance side shells are detachably connected to the functional device box. The inspection robot includes the robot mechanism, a robot movement assembly, and a vision assembly. The robot movement assembly is installed in the functional device box and is configured to drive the robot mechanism to move.

Abstract: The present invention provides the use of the gene or protein of adenylate kinase 6 (AK6) or the combination of AK6 and other 14 genes or proteins related to male infertility for (i) preparing the agent or kit for detecting male infertility; and/or (ii) preparing the pharmaceutical composition for contraception.

Abstract: A detection method for 305 fertility-associated sperm localization protein expressed in human testis and epididymis. The method includes qualitatively or quantitatively detecting for sperm localization proteins on a sperm or in seminal plasma via capture agents for the sperm localization proteins. The sperm localization proteins belong to an important protein group related to human sperm maturation and fertility. The method provides a diagnostic approach for male infertility.

Abstract: The present invention provides the use of the gene or protein of adenylate kinase 6 (AK6) or the combination of AK6 and other 14 genes or proteins related to male infertility for (i) preparing the agent or kit for detecting male infertility; and/or (ii) preparing the pharmaceutical composition for contraception.

Abstract: Provided in the present invention is an application for PRDX2 and/or PRDX6 in the preparation of a pharmaceutical composition to treat or prevent damage, aging or diseases resulting from an increase in reactive oxygen species (ROS).

Abstract: Provided in the present invention is an application for PRDX2 and/or PRDX6 in the preparation of a pharmaceutical composition to treat or prevent damage, aging or diseases resulting from an increase in reactive oxygen species (ROS).

Abstract: A detection method for 305 fertility-associated sperm localization protein expressed in human testis and epididymis. The method includes qualitatively or quantitatively detecting for sperm localization proteins on a sperm or in seminal plasma via capture agents for the sperm localization proteins. The sperm localization proteins belong to an important protein group related to human sperm maturation and fertility. The method provides a diagnostic approach for male infertility.